We rely on your tax-deductible donations to support our mission. Donate online →
Most Policy Initiative logo
Browse Research TOPICS

Syringe Access Programs

Written by Dr. Joshua Mueller and Dr. Ramon Martinez III
Published on November 28, 2022
Research Highlights

Missouri has a significant risk of outbreaks of hepatitis C and HIV due to injection drug use.

Syringe access programs (SAPs) decrease transmission of blood-borne infections for injection drug users by providing safe disposal and exchange of used syringes for new syringes.

When used with other health interventions, SAPs reduce other health risks such as addiction, overdose, and mortality.



**This Note has been updated since its original publication. Previous versions can be accessed here: Version 1 (December 2020) and Version 2 (January 2022).

Most Policy Initiative logo
238 E High St., 3rd Floor
Jefferson City, MO 65101
© 2024 MOST Policy Initiative | Website design and development by Pixel Jam Digital
Privacy Policy
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram